Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 505

1.

672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.

Wisnoski NC, Townsend CM Jr, Nealon WH, Freeman JL, Riall TS.

Surgery. 2008 Aug;144(2):141-8. doi: 10.1016/j.surg.2008.03.006. Epub 2008 May 27.

PMID:
18656619
2.

Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma.

Schmidt CM, Matos JM, Bentrem DJ, Talamonti MS, Lillemoe KD, Bilimoria KY.

J Gastrointest Surg. 2008 Dec;12(12):2078-86. doi: 10.1007/s11605-008-0705-6. Epub 2008 Oct 3.

PMID:
18836784
3.

Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.

Murphy MM, Simons JP, Hill JS, McDade TP, Chau Ng S, Whalen GF, Shah SA, Harrison LH Jr, Tseng JF.

Cancer. 2009 Sep 1;115(17):3979-90. doi: 10.1002/cncr.24433.

4.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
5.

Prognostic factors for survival in pancreatic cancer: a population-based study.

Eloubeidi MA, Desmond RA, Wilcox CM, Wilson RJ, Manchikalapati P, Fouad MM, Eltoum I, Vickers SM.

Am J Surg. 2006 Sep;192(3):322-9.

PMID:
16920426
6.

Pancreatic acinar cell carcinoma: a multi-institutional study.

Matos JM, Schmidt CM, Turrini O, Agaram NP, Niedergethmann M, Saeger HD, Merchant N, Johnson CS, Lillemoe KD, Gr├╝tzmann R.

J Gastrointest Surg. 2009 Aug;13(8):1495-502. doi: 10.1007/s11605-009-0938-z. Epub 2009 Jun 3.

PMID:
19495891
7.

Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.

Seth AK, Argani P, Campbell KA, Cameron JL, Pawlik TM, Schulick RD, Choti MA, Wolfgang CL.

J Gastrointest Surg. 2008 Jun;12(6):1061-7. Epub 2007 Oct 24.

PMID:
17957440
8.

Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society.

Kitagami H, Kondo S, Hirano S, Kawakami H, Egawa S, Tanaka M.

Pancreas. 2007 Jul;35(1):42-6.

PMID:
17575544
9.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
10.

Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S.

J Am Coll Surg. 2004 May;198(5):722-31.

PMID:
15110805
11.

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.

Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.

PMID:
18376190
12.

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Stessin AM, Meyer JE, Sherr DL.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128-33. doi: 10.1016/j.ijrobp.2008.02.065. Epub 2008 Jun 4.

PMID:
18538501
13.

Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.

Murphy MM, Simons JP, Ng SC, McDade TP, Smith JK, Shah SA, Zhou Z, Earle CC, Tseng JF.

Ann Surg Oncol. 2009 Nov;16(11):2968-77. doi: 10.1245/s10434-009-0656-5. Epub 2009 Aug 11.

PMID:
19669839
14.

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.

Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.

Ann Surg Oncol. 2008 Jan;15(1):165-74. Epub 2007 Sep 26.

PMID:
17896141
15.

The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.

Shaib Y, Davila J, Naumann C, El-Serag H.

Am J Gastroenterol. 2007 Jul;102(7):1377-82. Epub 2007 Mar 31.

PMID:
17403071
16.

[Prognostic factors influencing results of the surgical treatment of pancreatic cancer].

Ignashov AM, Kokhanenko NIu, Lisochkin BG, Savrasov VM, Volkov ON, Dvorakovskaia IV, Lebedev EG, Kulikov IuV.

Vestn Khir Im I I Grek. 2001;160(1):33-6. Russian.

PMID:
11258321
17.

Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States).

Cress RD, Yin D, Clarke L, Bold R, Holly EA.

Cancer Causes Control. 2006 May;17(4):403-9.

PMID:
16596292
18.

Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.

Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF.

Cancer. 2009 Feb 15;115(4):741-51. doi: 10.1002/cncr.24065.

19.

[Surgical resection of pancreatic cancer].

Magistrelli P, Antinori A, Crucitti A, La Greca A, Coppola R, Nuzzo G, Picciocchi A.

Tumori. 1999 Jan-Feb;85(1 Suppl 1):S22-6. Italian.

PMID:
10235076
20.

Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.

Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH, Fry RD, Caushaj PF, Kodner IJ.

J Am Coll Surg. 2002 Jul;195(1):33-40.

PMID:
12113543

Supplemental Content

Support Center